Civica Interested In Retired Or Withdrawn ANDAs

Seeks Talks With Manufacturers Over 250 ANDAs For Essential Medicines

As a part of its strategy to develop its own ANDAs for essential medications, Civica has expressed interest in taking over existing ANDAs that are being retired or withdrawn by other generics manufacturers.

Files
Civica stand ready to takeover ANDAs that may be retired or withdrawn • Source: Shutterstock

Hospital purchasing group Civica Rx says it is interested in talking to generics manufacturers which are considering retiring or withdrawing their abbreviated new drug applications for essential medicines that are at risk of being in short supply.

The announcement by the group with membership representing over 1,200 US hospitals came shortly after the US Food and Drug...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business